Literature DB >> 10998247

Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line.

S Abe-Dohmae1, S Suzuki, Y Wada, H Aburatani, D E Vance, S Yokoyama.   

Abstract

Murine macrophage RAW264 were investigated for their response to lipid-free apolipoproteins. Preincubation of the cells with 300 microM dibutyryl cyclic (dBc) AMP for 16 h induced specific binding of apolipoprotein (apo) A-I to the cells and apoA-I-mediated HDL formation with cellular lipids, neither of which was detected in the absence of dBcAMP. Dose-dependent changes of the apoA-I specific binding and the apoA-I-mediated cholesterol release were largely superimposable. ApoA-II also mediated lipid release after the treatment of the cells with dBcAMP and effectively displaced the apoA-I binding to the cells. In contrast, cellular cholesterol efflux to lipid microemulsion and to 2-(hydroxypropyl)-beta-cyclodextrin was uninfluenced by the dBcAMP treatment. To induce the cellular reactivity with apoA-I, the incubation with dBcAMP required at least 6 h. Actinomycin D, cycloheximide, puromycin, and brefeldin A suppressed both the induction of apoA-I-mediated lipid release and the apoA-I specific binding to the cells. Analysis of the expression level of ABC1 mRNA by using reverse transcription-polymerase chain reaction and oligonucleotide arrays revealed that ABC1 mRNA was already expressed in the dBcAMP-untreated cells, and the dBcAMP treatment for 16 h enhanced its expression 9-13-fold. We conclude that dBcAMP selectively induces apolipoprotein-mediated cellular lipid release and accordingly high-density lipoprotein generation by inducing specific binding of apolipoprotein, but does not influence diffusion-mediated lipid efflux. The cell-apolipoprotein interaction seems to depend on cellular protein biosynthesis and transport. A substantial increase in the level of ABC1 mRNA caused by the dBcAMP treatment indicates that ATP-binding cassette transporter 1, the protein product of ABC1, may directly be responsible for the interaction, but the question about the absence of the interaction with its baseline expression level remains.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998247     DOI: 10.1021/bi0008175

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Characterization of apoA-I-dependent lipid efflux from adipocytes and role of ABCA1.

Authors:  Alisha D Howard; Philip B Verghese; Estela L Arrese; Jose L Soulages
Journal:  Mol Cell Biochem       Date:  2010-06-10       Impact factor: 3.396

2.  Impact of self-association on function of apolipoprotein A-I.

Authors:  Shobini Jayaraman; Sumiko Abe-Dohmae; Shinji Yokoyama; Giorgio Cavigiolio
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

Review 3.  The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids.

Authors:  Guo-Jun Zhao; Kai Yin; Yu-Chang Fu; Chao-Ke Tang
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

4.  Direct detection of ABCA1-dependent HDL formation based on lipidation-induced hydrophobicity change in apoA-I.

Authors:  Risa Omura; Kohjiro Nagao; Norihiro Kobayashi; Kazumitsu Ueda; Hiroyuki Saito
Journal:  J Lipid Res       Date:  2014-09-11       Impact factor: 5.922

Review 5.  ATP binding cassette transporter A1--key roles in cellular lipid transport and atherosclerosis.

Authors:  Neelam Srivastava
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

6.  A novel gene regulator, pyrrole-imidazole polyamide targeting ABCA1 gene increases cholesterol efflux from macrophages and plasma HDL concentration.

Authors:  Akiko Tsunemi; Takahiro Ueno; Noboru Fukuda; Takayoshi Watanabe; Kazunobu Tahira; Akira Haketa; Yoshinari Hatanaka; Sho Tanaka; Taro Matsumoto; Yoshiaki Matsumoto; Hiroki Nagase; Masayoshi Soma
Journal:  J Mol Med (Berl)       Date:  2014-01-25       Impact factor: 4.599

7.  Sodium taurocholate-dependent lipid efflux by ABCA1: effects of W590S mutation on lipid translocation and apolipoprotein A-I dissociation.

Authors:  Kohjiro Nagao; Yu Zhao; Kei Takahashi; Yasuhisa Kimura; Kazumitsu Ueda
Journal:  J Lipid Res       Date:  2009-02-08       Impact factor: 5.922

8.  The role of hydrophobic and negatively charged surface patches of lipid-free apolipoprotein A-I in lipid binding and ABCA1-mediated cholesterol efflux.

Authors:  Loren E Smith; W Sean Davidson
Journal:  Biochim Biophys Acta       Date:  2009-09-24

9.  Direct interaction of nuclear liver X receptor-beta with ABCA1 modulates cholesterol efflux.

Authors:  Masako Hozoji; Youichi Munehira; Yuika Ikeda; Makoto Makishima; Michinori Matsuo; Noriyuki Kioka; Kazumitsu Ueda
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

10.  Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis.

Authors:  Reijiro Arakawa; Maki Tsujita; Noriyuki Iwamoto; Chisato Ito-Ohsumi; Rui Lu; Chen-Ai Wu; Kenji Shimizu; Tomoji Aotsuka; Hashime Kanazawa; Sumiko Abe-Dohmae; Shinji Yokoyama
Journal:  J Lipid Res       Date:  2009-05-20       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.